Interleukin-6 trans-signalling and risk of future cardiovascular events: a new avenue for atheroprotection?

Cardiovasc Res. 2019 Jan 1;115(1):8-9. doi: 10.1093/cvr/cvy233.
No abstract available

Publication types

  • Editorial
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Cardiovascular Diseases*
  • Humans
  • Interleukin-6*
  • Signal Transduction

Substances

  • Interleukin-6